Alterity Therapeutics Limited (ATHE)

NASDAQ: ATHE · Real-Time Price · USD

4.565

0.00 (0.00%)

Jul 29, 2026, 11:35 AM EDT - Market open

Alterity Therapeutics Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Net Income	-	-12.15	-19.12	-13.81	-12.85	-15.31
Depreciation & Amortization	-	0.14	0.15	0.1	0.05	0.08
Stock-Based Compensation	-	0.98	0.88	0.97	1.51	1.88
Other Adjustments	-	0.19	-0.26	-0.91	-2.81	0.43
Change in Receivables	-	0.1	4.62	-3.94	-0.45	-4.22
Changes in Accounts Payable	-	-2.04	1.1	-1.56	2.6	0.43
Changes in Accrued Expenses	-	0.25	-0.23	0.08	0.12	-0.11
Changes in Income Taxes Payable	-0.06	-0.07	-0.06	-0.1	-0.04	-
Changes in Other Operating Activities	-15.29	-10.3	-12.29	-20.9	-12.81	-17.85
Operating Cash Flow	-15.35	-11.45	-12.61	-20.04	-12.34	-17.33
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Capital Expenditures	-	-	-0.01	-0.01	-0.09	-0.01
Purchases of Investments	-	-7.5	-	-	-	-
Other Investing Activities	-	-	-	-0.03	-	-
Investing Cash Flow	7.5	-7.5	-0.01	-0.04	-0.09	-0.01

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Issuance of Common Stock	20.38	42.57	10.14	0.32	17.18	39.24
Net Common Stock Issued (Repurchased)	20.38	42.57	10.14	0.32	17.18	39.24
Other Financing Activities	-1.21	-2.9	-0.93	-0.19	-0.87	-2.55
Financing Cash Flow	19.17	39.67	9.22	0.12	16.3	36.69

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Foreign Exchange Rate Adjustments	-0.04	-0.2	0.26	0.91	2.81	-0.43
Net Cash Flow	11.28	20.72	-3.4	-19.95	3.88	19.35

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-15.35	-11.45	-12.61	-20.04	-12.43	-17.34
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-	-149.86%	-313.78%	-511.78%	-242.54%	-386.62%
Free Cash Flow Per Share	-47.35	-53.70	-103.69	-247.67	-154.94	-
Levered Free Cash Flow	-15.35	-24.18	-30.46	-36.2	-23.01	-32.77
Unlevered Free Cash Flow	-15.35	-24.42	-30.9	-36.95	-25.58	-32.62

SEC Filings: 10-K · 10-Q